Mount Sinai Researchers Identify Blood RNA Biomarkers for Alzheimer’s Detection
The study highlights the role of brain-derived nanoparticles in identifying the disease through minimally invasive testing.
Read More
Search Results for: genetic testing
Quest Gains New York Approval for Haystack MRD Cancer Monitoring Test
The approval allows Quest Diagnostics to offer its minimal residual disease test for patients in all 50 states.
Read More
Myriad Genetics Expands Minimal Residual Disease Testing for Three Cancer Types
The whole-genome sequencing assay is now available for breast, colorectal, and renal cancers following new clinical study results.
Read More
Labcorp Launches RNA-Based At-Home Colorectal Cancer Test Nationwide
The test detect signs of colorectal cancer and precancerous growths using a home collection kit.
Read More
AI Reasoning Model Helps Identify Leads for Rare Disease Diagnoses
A study reports that an OpenAI reasoning model improved rare disease diagnostic yield by 4.8% in previously unsolved cases, offering new leads after specialist analysis.
Read More